{
    "nctId": "NCT03249272",
    "officialTitle": "Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve",
    "inclusionCriteria": "* Men or women aged 18 years or older\n\nCardiomyopathy patients\n\n* Patients presenting for CMR with the clinical diagnosis of hypertrophic cardiomyopathy based on left ventricular wall thickness of at least \u226515 mm in the absence of any other cardiac or systemic cause of hypertrophy\n* Patients presenting for CMR with the clinical diagnosis of idiopathic dilated cardiomyopathy based upon left ventricular ejection fraction \u226440%, LV end-diastolic diameter \u226555 mm or left ventricular end-systolic diameter \u226445 mm, and the absence of coronary stenoses on angiography.\n\nControl patients\n\n* Patients presenting for CMR without evidence of obstructive coronary artery disease either by coronary angiography or stress testing.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Decompensated heart failure or hemodynamic instability\n* Prior coronary revascularization (PCI or CABG) or myocardial infarction (as evidenced by previously elevated CPK-MB or troponin levels)\n* Accelerating angina or unstable angina\n* Inability to physically tolerate MRI or implanted objects that are MRI incompatible\n* Inability to provide written informed consent obtained at time of study enrollment.\n* Severe claustrophobia\n* Advanced heart block or sinus node dysfunction\n* Hypersensitivity or allergic reaction to regadenoson or adenosine\n* Hypotension\n* Active bronchospasm or history of hospitalization due to bronchospasm\n* History of seizures\n* Recent cerebrovascular accident\n* Use of dipyridamole within the last 5 days\n* Contraindication to aminophylline\n* Severe renal insufficiency with estimated glomerular filtration rate \\<30 ml/min/ 1.73 m2\n* Pregnant or nursing"
}